OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neoadjuvant drug-eluting bead transarterial chemoembolization and tislelizumab therapy for resectable or borderline resectable hepatocellular carcinoma: A propensity score matching analysis
Jianping Zhao, Jingjing Wang, Yuanxiang Lu, et al.
European Journal of Surgical Oncology (2023) Vol. 49, Iss. 12, pp. 107106-107106
Open Access | Times Cited: 12
Jianping Zhao, Jingjing Wang, Yuanxiang Lu, et al.
European Journal of Surgical Oncology (2023) Vol. 49, Iss. 12, pp. 107106-107106
Open Access | Times Cited: 12
Showing 12 citing articles:
Neoadjuvant therapy: Dawn of reducing the high post-surgery recurrence rate of hepatocellular carcinoma
Xiaodong Zhang, Luyi Zhang, Jialiang Luo, et al.
World Journal of Gastrointestinal Surgery (2025) Vol. 17, Iss. 3
Closed Access
Xiaodong Zhang, Luyi Zhang, Jialiang Luo, et al.
World Journal of Gastrointestinal Surgery (2025) Vol. 17, Iss. 3
Closed Access
Proposal for Prognosis-Oriented Definition of Borderline Resectable Hepatocellular Carcinoma
Koichiro Haruki, Norifumi Harimoto, Kenei Furukawa, et al.
Journal of the American College of Surgeons (2024) Vol. 238, Iss. 6, pp. 1137-1147
Closed Access | Times Cited: 2
Koichiro Haruki, Norifumi Harimoto, Kenei Furukawa, et al.
Journal of the American College of Surgeons (2024) Vol. 238, Iss. 6, pp. 1137-1147
Closed Access | Times Cited: 2
Neoadjuvant targeted immunotherapy followed by surgical resection versus upfront surgery for hepatocellular carcinoma with macrovascular invasion: A multicenter study
Xiangan Wu, Yuxin Wang, Sen Wang, et al.
Journal of Cancer (2024) Vol. 15, Iss. 10, pp. 3024-3033
Open Access | Times Cited: 2
Xiangan Wu, Yuxin Wang, Sen Wang, et al.
Journal of Cancer (2024) Vol. 15, Iss. 10, pp. 3024-3033
Open Access | Times Cited: 2
Recent advances in surgical management strategies for hepatocellular carcinoma
Zhen‐Bin Ding, Ying‐Hong Shi, Jiafeng Chen, et al.
hLife (2024) Vol. 2, Iss. 9, pp. 439-453
Open Access | Times Cited: 2
Zhen‐Bin Ding, Ying‐Hong Shi, Jiafeng Chen, et al.
hLife (2024) Vol. 2, Iss. 9, pp. 439-453
Open Access | Times Cited: 2
Neoadjuvant-Based Triple Therapy for Hepatocellular Carcinoma with Type I/II Portal Vein Tumor Thrombosis
Guimin Hou, Feng Zhang, Xielin Feng, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1581-1595
Open Access | Times Cited: 2
Guimin Hou, Feng Zhang, Xielin Feng, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1581-1595
Open Access | Times Cited: 2
Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced HCC
Zhenyun Yang, Qianyu Wang, Hu Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Zhenyun Yang, Qianyu Wang, Hu Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Consensus of Chinese Experts on Neoadjuvant and Conversion Therapies for Hepatocellular Carcinoma: 2023 Update
Xinyu Bi, Haitao Zhao, Hong Zhao, et al.
Liver Cancer (2024), pp. 1-16
Open Access | Times Cited: 1
Xinyu Bi, Haitao Zhao, Hong Zhao, et al.
Liver Cancer (2024), pp. 1-16
Open Access | Times Cited: 1
Letter to the editor: Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study
Jianping Zhao, Jingjing Wang, Wanguang Zhang
International Journal of Surgery (2024) Vol. 110, Iss. 7, pp. 4409-4410
Open Access
Jianping Zhao, Jingjing Wang, Wanguang Zhang
International Journal of Surgery (2024) Vol. 110, Iss. 7, pp. 4409-4410
Open Access
Letter to editor: “identification of patients with favorable prognosis after resection in intermediate-stage hepatocellular carcinoma”
You‐Jian Xu, Hui‐Ming Pang
International Journal of Surgery (2024) Vol. 110, Iss. 9, pp. 5916-5917
Open Access
You‐Jian Xu, Hui‐Ming Pang
International Journal of Surgery (2024) Vol. 110, Iss. 9, pp. 5916-5917
Open Access
Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced hepatocellular carcinoma
Zhenyun Yang, Qianyu Wang, Hu Li, et al.
Research Square (Research Square) (2024)
Open Access
Zhenyun Yang, Qianyu Wang, Hu Li, et al.
Research Square (Research Square) (2024)
Open Access
Transarterial chemoembolization combined with lenvatinib plus tislelizumab for unresectable hepatocellular carcinoma: a multicenter cohort study
Yushan Zhao, Wen Shu-wei, YaoQing Xue, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Yushan Zhao, Wen Shu-wei, YaoQing Xue, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Prognosis of Neoadjuvant HAIC and Lenvatinib Followed by Surgery versus Direct Resection for Resectable or Borderline Resectable Hepatocellular Carcinoma: A Real-World Study
Yuan Shi, Chaoyu Chen, Xinlin Li, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 2063-2076
Open Access
Yuan Shi, Chaoyu Chen, Xinlin Li, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 2063-2076
Open Access
